medical education within nephrocare - uems.eu · page 2 our vision is to improve quality of life...

Medical Education within NephroCare Dr. Berit Goethel

The fourth UEMS conference on CME-CPD

Brussels, 24th November 2018

Our vision is to improve Quality of Life &

clinical outcomes for our patients

Medical Education within NephroCare, B. Goethel, UEMS congress Nov 2018

Fresenius as a global operating company is „industry“


Fresenius Medical Care is member of the Fresenius Group

Ownership: ~31% Ownership: 100% Ownership: 100% Ownership: 77%

Dialysis Products

Health Care Services

Hospital Supplies Hospital Operation Projects and Services for

Hospitals

• Dialysis services • Hemodialysis products • Peritoneal dialysis products • Care coordination

Revenue 2017: EUR 17.8 bn

• IV drugs • Biosimilars • Clinical nutrition • Infusion therapy • Medical devices/

Transfusion technology Revenue 2017: EUR 6.4 bn

• Acute care and post-acute care

• Expertise in all areas and at all levels of medical care

Revenue 2017: EUR 8.7 bn

• Project development • Planning • Turnkey construction • Maintenance • Technical and total

operational management Revenue 2017: EUR 1.2 bn


Fresenius Medical Care operates globally

My question: outside nephroCare, who is running the clinics?

> 3,750 own dialysis centers in 2017

> 320,950 patients haven been treated

> 48 M dialysis treatments performed

In around 50 countries

Patient growth of ~6 % p.a. worldwide


Our starting point with UEMS was challenging


Is there a possibility to move on?


NephroCare as service brand of FMC employs physicians and cares for > 100.000 patients

26/11/2018 NephroCare @ Fresenius Medical Care Deutschland GmbH Head office: Fresenius Medical Care Deutschland GmbH · 61346 Bad Homburg v. d. H. · Germany

Phone: +49 (0) 6172-609-0 · Fax: +49 (0) 6172-609-2191

8

NephroCare EMEA LA 2017

NephroCare Clinics > 980

Patients > 100,000

Employees > 29,000

Treatments ~13,9 M

For Europe, Middle East and Africa (EMEA):

~2.000 physicians

6,914

6,538

6,001 5,851

4,932 4,788 4,708

3,938

2,834 2,657 2,638

2,201 1,954

1,617

1,103 1,025

340 290 270 223 174 166 36 34

0

1,000

2,000

3,000

4,000

5,000

6,000

7,000

8,000

Over 60.000 chronic HD patients* are treated within NephroCare EMEA

Hemodialysis patients:

Oct 2018: ~ 63,000 All

patients

, n

*: excluding Home HD


NephroCare offers a comprehensive range of services

for patients with chronic renal failure

Patient engagement

• care


Clinical & Therapeutical Governance is responsible for

outcomes, QoL and values

Risks prevention & management

Stakeholders satisfaction

Patients


We are convinced


Medical Education

Improve

patient clinical outcomes &

quality of life

Accredited medical education

is of high quality, supporting physicians

with collecting credits

We are creating values by offering medical education


NephroCare Measure of Effectiveness

Stuard © 2018 NephroCare Annual Meeting

Prevalent Patients: Morbidity (crude data) National Research Council (CNR*) evaluation

EMEA NHSs: Less hospitalization days 110.000 x 3,7 = 407.000 days ~ 101.7 milio € saving (Cost of hospidalization/day: 250€)

• *CNR is the largest public research institution in Italy, the only one reporting to the Research Ministry • # worst case scenario in case patients were dialyzed in our clinics during the hospitalization (10%)

Dec 2014 - Sept 2018

26/11/2018 Stuard © 2018 NephroCare Annual Meeting

Our starting point with UEMS was challenging


How did we move on after this „yes“?


Our first material

Main author:

Dr. Stefano Stuard

Reviewers elearning:

Internal:

Dr. O. Arkossy

Prof. G. Imamovic

Dr. Janos Termeg

Nicole Voigt

Dr. Berit Göthel

External:

Prof. D. Brancaccio


We have received UEMS accreditation

LEE:

Country Medical

Directors

Meeting 2018

ELM:

Chronic Kidney

Disease Mineral

Bone Disorder

ERA-EDTA: = European Renal Association – European Dialysis and Transplant Association

ELM:

Blood pressure

management in

Chronic Kidney

Disease


EMEA CMDs meeting is an international scientific congress


Accredited material available via NephroCare Academy

NephroCare physicians will be enrolled to the

courses


NephroCare Academy website


Key points

Why NephroCare receives UEMS accreditation

Patients are treated in NephroCare clinics in EMEA

NephroCare physicians are responsible for

• the quality of the treatment delivered to the patients

• the patients intermediate and final clinical outcomes

NephroCare is responsible for the continuing medical education of its physicians


In the future, we want to develop more content

Main author:

Stefano Stuard

Reviewers: Country Medical Directors (CMDs) of 26 EMEA countries

19 chapters

>600 references


We want to establish a central accreditation office

Care mgmt. & coaching

(risk-based) • Case manager • Self-mgmt. training • Coordination

between care givers

Supported by NephroCare’s high clinical quality, processes and governance

Risk stratification

• Progression • Hospitalizations

Educational courses

Scientific Meetings

Improved patient clinical outcomes &

quality of life

Central Accreditation office


Our vision is to improve Quality of Life &

clinical outcomes for our patients

This is us

Dr. S. Stuard

S. Ramakers

Dr. M. Savoia

Dr. B. Göthel

Dr. O. Arkossy

Dr. V. Kovarova

L. Constantinescu I. Morris

Prof. D. Brancaccio

Dr. J. Merello

Country Medical Directors of 30

countries

N. Voigt

Dr. J. Termeg


medical education within nephrocare - uems.eu · page 2 our vision is to improve quality of life...

Documents